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Effects of Highly Active Antiretroviral Therapy
(HAART) on Pulmonary Arteries
HAART consists of at least three antiretroviral drugs that
suppress viral replication and restore CD4 T-cell num-
bers in HIV-infected patients. HAART dramatically im-
proves the prognosis of HIV-infected patients; however,
HAART drugs may increase the risk of cardiovascular
disease. Wang et al (Am J Pathol 2009, 174: 771–781)
hypothesized that HAART drugs mediate this effect by
impairing endothelial function. Studies demonstrated that
treatment of porcine pulmonary arteries with HAART
drugs individually and in combination resulted in a lower
vasorelaxation response, lower endothelial nitric oxide
synthase levels, and higher levels of oxidative stress.
Therefore, HAART drugs may play a role in the high
incidence of pulmonary artery hypertension in HIV-in-
fected patients.
Neprilysin Protects against Hypoxic
Pulmonary Hypertension
Neprilysin, a protein expressed within the lung vascula-
ture, breaks down neuropeptides that regulate both
growth and contraction of smooth muscle cells. Vascular
remodeling through smooth muscle cell growth and pro-
liferation contributes to the severity of chronic hypoxic
pulmonary hypertension (PHTN). To determine whether
depletion of neprilysin increased susceptibility to PHTN in
response to chronic hypoxia, Dempsey et al (Am J Pathol
2009, 174: 782–796) generated a mouse model deficient
in neprilysin. Although neprilysin deficiency had minimal
effects on baseline cardiac and pulmonary function, on
hypoxic exposure, neprilysin-deficient mice had an aug-
mented pulmonary hypertensive response. In addition,
Dempsey and colleagues observed increased prolifera-
tion of pulmonary smooth muscle cells in these mice,
which was reduced on reintroduction of neprilysin. Thus,
introduction of neprilysin into the lungs of PHTN patients
may provide a novel treatment for PHTN.
Neurodegeneration Can Be Caused by Cell
Proliferation
The causes of cell death in neurodegenerative patholo-
gies such as Alzheimer’s and Parkinson’s diseases are
incompletely understood. Mature neurons in healthy indi-
viduals are postmitotic and quiescent; however, degen-
erating neurons up-regulate c-Myc (Myc), a cell-cycle
regulatory protein and oncogene. This led Lee et al (Am J
Pathol 2009, 174: 891–897) to hypothesize that cell cycle
re-entry contributes to neurodegenerative pathogenesis.
They found that expression of Myc in forebrain neurons
resulted in re-entry of the cell cycle, as determined by
expression of cell-cycle markers and DNA replication.
Furthermore, Myc expression resulted in neural cell
death, gliosis, and cognitive defects. Neurodegenera-
tion, therefore, may be a disease of dysregulated cell-
cycle control, and cell-cycle regulators should be ex-
plored as future treatment targets.
A New Model for Plague Vaccine Studies
Pneumonic plague is the most virulent form of infection
caused by Yersinia pestis. Multiple animal models must
be used to evaluate the efficacy of plague vaccines
because human clinical trials that test new vaccines are
not feasible. Anderson et al (Am J Pathol 2009, 174:
910–921) propose using Brown Norway rats as an alter-
nate model to mice for studying plague vaccine perfor-
mance because of their larger size and epidemiological
association with Y. pestis infection. These rats succumb to
pneumonic plague rapidly, within 2 to 4 days, with similar
disease progression as in humans. Brown Norway rats
could be protected from disease by vaccination with either
the protective antigen LcrV or its mutant derivative V10.
These rats also produced neutralizing antibodies specific to
multiple epitopes on LcrV. These results validate the use of
Brown Norway rats to study plague pathogenesis and
immunity.
High Cholesterol Increases Tumor
Angiogenesis and Promotes Progression in
Prostate Cancer
Dietary cholesterol has been linked to the progression of
prostate cancer. To determine whether high circulating
cholesterol levels promote the growth of prostate tumors,
Solomon et al (Am J Pathol 2009, 174: 1017–1026) ex-
amined the effects of hypercholesterolemia on tumor pro-
gression in a human prostate cancer xenotransplantation
model in the presence and absence of Ezetimibe, a
cholesterol uptake-blocking drug. They found that high
serum cholesterol levels induced by a high-fat/high-cho-
lesterol Western diet promoted tumor growth and that
Ezetimibe could inhibit this increased tumor growth. High
circulating cholesterol levels also affected angiogenesis,
resulting in increased microvessel density and other in-
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dicators of vascularity. This increase in angiogenesis
was blocked by Ezetimibe treatment, possibly through
up-regulation of the angiogenesis-inhibiting molecule
thrombospondin-1. These data suggest that reducing
serum cholesterol levels may inhibit prostate cancer
growth specifically by inhibiting tumor angiogenesis.
Hemorrhage-Associated Macrophages
(HA-mac) Are Atheroprotective
Conventional lipid-scavenging macrophages in athero-
sclerotic lesions exacerbate disease through the secre-
tion of pro-inflammatory cytokines; however, macro-
phages found in hemorrhaged atherosclerotic plaques
secrete the atheroprotective cytokine IL-10. Boyle et al
(Am J Pathol 2009, 174: 1097–1108) examined the mac-
rophage phenotype in hemorrhaged atherosclerotic
plaques and found a novel population of macrophages,
HA-macs, that expressed high levels of CD163, the mac-
rophage scavenger receptor that binds hemoglobin-hap-
toglobin (HbHp), and low levels of HLA-DR. These HA-
macs caused less oxidative damage and produced lower
levels of hydrogen peroxide and superreactive oxygen
species than conventional pro-atherogenic macro-
phages. HA-mac differentiation was driven by both HbHp
and IL-10 expression and could be reproduced in vitro.
Skewing macrophage differentiation to atheroprotective
HA-mac may comprise a new cardioprotective therapeu-
tic strategy.
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